Event
The Nexus of IP and R&D: Applying Insights to Accelerate Innovation
Christine Goddard, a principal in Fish’s Boston office, will be a panelist for IPWatchdog’s The Nexus of IP and R&D: Applying Insights to Accelerate Innovation webinar, on June 23.
IPWatchdog is one of the leading sources for news and information in the patent and innovation industries. They frequently host webinars on hot topics, including IP ethics, standard essential patents, and patent eligibility, among others. Panel details are below:
The Nexus of IP and R&D: Applying Insights to Accelerate Innovation
Wednesday, June 23 | 12:00 - 1:00PM ET
The transformation of intellectual property (IP) management within commercial companies is driving the adoption of new practices and technologies to more closely align IP objectives with growth strategies, unlock greater portfolio value, and support strategic decision-making across enterprises. Nowhere is that more critical than at the nexus of IP and Research and Development (R&D), where organizations are applying IP insights to accelerate scientific breakthroughs and identify potential risks to commercialization earlier in the product lifecycle.
Missing critical IP information during R&D can lead to a misallocated resources, potential patent entanglements downstream, and delays in commercialization.
During our webinar you’ll learn important ways to use IP insights to accelerate R&D:
- Solutions to the challenges facing R&D and IP managers in sharing and using information
- How companies are collaborating to improve decision-making with IP insights
- Key insights to consider to clarify investment directions and mitigate risks
Panelists:
- Christine Goddard, Principal, Fish & Richardson
- Matthew McBride, Director of IP Services, CAS
- Gene Quinn, President, IPWatchdog, Inc.
For more information, or to register, click here.
Upcoming events
Related thought leadership
Blog June 2, 2025
Navigating Change at the USPTO
Blog May 23, 2025
John Squires Faces the Senate Judiciary Committee
Article May 9, 2025
Patent Diligence for VCs and PEs
Blog May 7, 2025
Federal Circuit Clarifies Limits of Patent Eligibility for Machine Learning Claims
Blog April 28, 2025
Can Clinical Trials Negate Patentability for Pharma Inventions?
Blog April 16, 2025
Key Insights From the UPC’s First SEP Decision
Blog March 18, 2025
Federal Circuit: PTE for Reissue Patents Should Be Calculated From Original Patent’s Issue Date
Blog March 14, 2025
Trump Nominates John Squires as USPTO Director: Here’s What to Watch
Blog February 18, 2025
How Startups Can Position Their IP Portfolios to Attract Investors
Blog January 21, 2025
How Standardization, SEPs, and Patent Pools Can Benefit the EV and Battery Industries